Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer

Darian Andreas; Jeffrey J. Tosoian; Patricia Landis; Sacha Wolf; Stephanie Glavaris; Tamara L. Lotan; Edward M. Schaeffer; Lori J. Sokoll; Ashley E. Ross

doi:10.1016/j.eucr.2016.04.012

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer

Darian Andreas, Jeffrey J. Tosoian, Patricia Landis, Sacha Wolf, Stephanie Glavaris, Tamara L. Lotan, Edward M. Schaeffer, Lori J. Sokoll, Ashley E. Ross

School of Medicine

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The Prostate Health Index (phi) has been FDA approved for decision-making regarding prostate biopsy. Phi has additionally been shown to positively correlate with tumor volume, extraprostatic disease and higher Gleason grade tumors. Here we describe a case in which an elevated phi encouraged biopsy of a gentleman undergoing active surveillance leading to reclassification of his disease as high risk prostate cancer.

Original language	English (US)
Pages (from-to)	64-66
Number of pages	3
Journal	Urology Case Reports
Volume	7
DOIs	https://doi.org/10.1016/j.eucr.2016.04.012
State	Published - Jul 1 2016

Keywords

Active surveillance
Biomarkers
Prostate biopsy
Prostate cancer

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eucr.2016.04.012

Cite this

@article{1ae7ae7a22934cc7814c2bcc8e112e20,

title = "Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer",

abstract = "The Prostate Health Index (phi) has been FDA approved for decision-making regarding prostate biopsy. Phi has additionally been shown to positively correlate with tumor volume, extraprostatic disease and higher Gleason grade tumors. Here we describe a case in which an elevated phi encouraged biopsy of a gentleman undergoing active surveillance leading to reclassification of his disease as high risk prostate cancer.",

keywords = "Active surveillance, Biomarkers, Prostate biopsy, Prostate cancer",

author = "Darian Andreas and Tosoian, {Jeffrey J.} and Patricia Landis and Sacha Wolf and Stephanie Glavaris and Lotan, {Tamara L.} and Schaeffer, {Edward M.} and Sokoll, {Lori J.} and Ross, {Ashley E.}",

note = "Publisher Copyright: {\textcopyright} 2016 The Authors.",

year = "2016",

month = jul,

day = "1",

doi = "10.1016/j.eucr.2016.04.012",

language = "English (US)",

volume = "7",

pages = "64--66",

journal = "Urology Case Reports",

issn = "2214-4420",

publisher = "Elsevier Saunders",

}

TY - JOUR

T1 - Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer

AU - Andreas, Darian

AU - Tosoian, Jeffrey J.

AU - Landis, Patricia

AU - Wolf, Sacha

AU - Glavaris, Stephanie

AU - Lotan, Tamara L.

AU - Schaeffer, Edward M.

AU - Sokoll, Lori J.

AU - Ross, Ashley E.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - The Prostate Health Index (phi) has been FDA approved for decision-making regarding prostate biopsy. Phi has additionally been shown to positively correlate with tumor volume, extraprostatic disease and higher Gleason grade tumors. Here we describe a case in which an elevated phi encouraged biopsy of a gentleman undergoing active surveillance leading to reclassification of his disease as high risk prostate cancer.

AB - The Prostate Health Index (phi) has been FDA approved for decision-making regarding prostate biopsy. Phi has additionally been shown to positively correlate with tumor volume, extraprostatic disease and higher Gleason grade tumors. Here we describe a case in which an elevated phi encouraged biopsy of a gentleman undergoing active surveillance leading to reclassification of his disease as high risk prostate cancer.

KW - Active surveillance

KW - Biomarkers

KW - Prostate biopsy

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84969627274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969627274&partnerID=8YFLogxK

U2 - 10.1016/j.eucr.2016.04.012

DO - 10.1016/j.eucr.2016.04.012

M3 - Article

C2 - 27335798

AN - SCOPUS:84969627274

SN - 2214-4420

VL - 7

SP - 64

EP - 66

JO - Urology Case Reports

JF - Urology Case Reports

ER -

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this